P/118/2010

Key facts

Active substance
Chimeric antibody to mesothelin (MORAB-009)
Therapeutic area
Oncology
Decision number
P/118/2010
PIP number
P/118/2010
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Mesothelioma
Route(s) of administration
Intravenous use
Contact for public enquiries
Eisai Ltd

E-mail: angela_miller@eisai.net
Country: United Kingdom
Phone: +44 8456765089

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating